Form 4 for PVLA PALVELLA THERAPEUTICS, INC.
Accepted 2026-06-16 16:05:22 ET · period of report 2026-06-12 · accession 0001104659-26-074574 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-16 16:05 | 2026-06-12 | PVLA | Korenberg Matthew E | CFO, Treas | M - OptEx | $13.60 | +1,000 | 1,000 | New | +$13.6K |
| D | 2026-06-16 16:05 | 2026-06-12 | PVLA | Korenberg Matthew E | CFO, Treas | M - OptEx | $0.00 | -1,000 | 166.1K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-12 | M | A | 1,000 | $13.60 | 1,000 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-12 | M | D | 1,000 | $0.00 | 166,100 | D | $13.60 · — to 2034-12-13 | 1,000 Common Stock | (F1) 25% of the stock options will vest on October 16, 2025, and the remaining 75% will vest in equal monthly tranches over the following 36 months. |